{
    "organizations": [],
    "uuid": "f6c86b8a5bb4f69bccd0c28b476c4219554d6dee",
    "author": "Timothy W. Martin",
    "url": "https://www.wsj.com/articles/samsungs-6-billion-stock-wipeout-marks-latest-flare-up-over-2015-merger-1525349868",
    "ord_in_thread": 0,
    "title": "Samsung’s $6 Billion Stock Wipeout Marks Latest Flare-Up Over 2015 Merger",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SEOUL—A merger of two Samsung affiliates in 2015 is drawing fresh scrutiny this week, wiping out billions of dollars of stock-market value and creating new headaches for South Korea’s biggest conglomerate.\nOn Tuesday, the country’s financial regulators issued a warning to Samsung Biologics Co., the conglomerate’s contract drug-manufacturing arm, for alleged accounting irregularities, triggering a two-day stock selloff that has erased $6 billion from the company’s market capitalization.\n... To Read the Full Story Subscribe Sign In",
    "published": "2018-05-03T16:17:00.000+03:00",
    "crawled": "2018-05-03T16:13:33.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "merger",
        "two",
        "samsung",
        "affiliate",
        "drawing",
        "fresh",
        "scrutiny",
        "week",
        "wiping",
        "billion",
        "dollar",
        "value",
        "creating",
        "new",
        "headache",
        "south",
        "korea",
        "biggest",
        "conglomerate",
        "tuesday",
        "country",
        "financial",
        "regulator",
        "issued",
        "warning",
        "samsung",
        "biologics",
        "conglomerate",
        "contract",
        "arm",
        "alleged",
        "accounting",
        "irregularity",
        "triggering",
        "stock",
        "selloff",
        "erased",
        "billion",
        "company",
        "market",
        "capitalization",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}